Genus Capital Management’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-403
Closed -$228K 214
2025
Q4
$228K Buy
+403
New +$215K 0.03% 183
2025
Q3
Sell
-1,182
Closed -$642K 209
2025
Q2
$642K Sell
1,182
-607
-34% -$317K 0.08% 136
2025
Q1
$886K Buy
+1,789
New +$989K 0.13% 127
2024
Q2
Sell
-24,056
Closed -$9.58M 290
2024
Q1
$9.6M Buy
+24,056
New +$9.09M 1.25% 17
2023
Q4
Sell
-27,075
Closed -$8.07M 283
2023
Q3
$7.91M Buy
27,075
+150
+0.6% +$46.8K 1.25% 21
2023
Q2
$9.21M Buy
+26,925
New +$8.15M 1.36% 18

Other funds holding ISRG

Genus Capital Management's ISRG Position: Q1 2026 in Review

Genus Capital Management sold out of Intuitive Surgical (ISRG) in Q1 2026, closing a stake of 403 shares — an estimated $228K sold.

Genus Capital Management first reported a position in ISRG in Q2 2023 and held it in 6 quarters. The position peaked at $9.6M in Q1 2024. 2,314 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Genus Capital Management reported no remaining Intuitive Surgical position as of Q1 2026 after selling out during the quarter.
  • Genus Capital Management sold 403 Intuitive Surgical shares in Q1 2026, an estimated $228K.
  • Genus Capital Management first reported a position in Intuitive Surgical in Q2 2023 and held it in 6 quarters.
  • Genus Capital Management's Intuitive Surgical position peaked at $9.6M in Q1 2024.
  • 2,314 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Genus Capital Management's 13F filing for Q1 2026, filed 4 May 2026.